Queen Creek PRP Ledger
What do people ask about PRP Queen Creek?
Start with what the shot is. PRP stands for platelet-rich plasma and uses only part of your own blood.
Platelets are blood cells that collect at a cut and release signals that start repair. The office spins your blood, keeps the layer with more platelets and uses that layer for the shot.
Does PRP work?
Sometimes people report less soreness, but nobody can promise a result. What happens can differ by the body part, the cause and how the blood layer was made. Ask what relief might be reasonable for your exact sore spot. Also ask when you'll know whether the shot helped.
What is PRP made from?
It comes only from your blood. The clinic spins the blood, separates its layers and keeps one layer with more platelets. That layer goes into the sore joint or by the sore tendon as a shot. Clinics may keep different amounts, so one result doesn't cover every type of PRP.
What happens at a QC Kinetix visit?
Your examiner checks the sore area and reviews your health. QC Kinetix calls that examiner a medical provider, so ask if you'll see a doctor, nurse or another trained team member. Regenerative treatments are its non-surgery choices, which may include PRP made there from your blood. The findings can rule out a shot, so get the price and later care needs before deciding.
What can go wrong after PRP?
Soreness and swelling can happen after the shot. Bleeding and infection are also possible, so the office needs your medicines and health history. Get care now for fever and a joint that's hot and swollen, redness that spreads, drainage or major weakness. Written care notes need to say whom you'll call if trouble starts.
What will you pay for PRP?
This site doesn't list a price because the clinic's current charge isn't given here. Ask for a written total and check exactly what it covers. The exam, shot, supplies and later visits may have separate charges. Don't agree until you know the full cost.
Is PRP covered by insurance?
For a joint or tendon, you'll usually pay cash for PRP. Medicare pays only for certain wounds that won't heal when care is part of an approved study. Check your own plan with both the insurer and clinic. Payment for an exam or exercise care doesn't mean the plan also pays for PRP.
Sources
-
In the RESTORE trial - the largest placebo-controlled PRP trial in knee osteoarthritis - 288 adults aged 50+ with symptomatic Kellgren-Lawrence grade 2-3 medial knee OA received three weekly intra-articular injections of leukocyte-poor PRP from a commercial system or saline placebo. At 12 months the mean change in knee pain was -2.1 points with PRP versus -1.8 with saline (difference -0.4; 95% CI -0.9 to 0.2; P=.17) against a minimum clinically important difference of 1.8, and the change in medial tibial cartilage volume was -1.4% versus -1.2% (difference -0.2%; 95% CI -1.9% to 1.5%; P=.81). Twenty-nine of 31 prespecified secondary outcomes showed no significant between-group difference. The authors concluded the findings do not support use of PRP for knee OA.
Bennell KL, Paterson KL, Metcalf BR, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial. JAMA, 2021. DOI: 10.1001/jama.2021.19415.
-
A Bayesian network meta-analysis restricted to LARGE randomized trials (at least 100 patients per group; 57 trials, 22,795 participants, 18 intra-articular interventions) found treatment effects were larger in the 35 high-risk-of-bias trials than in the 22 low/unclear-risk trials. Excluding high-risk trials, the effects of 16 of the 18 intra-articular interventions in knee or hip OA were smaller than the minimal clinically important difference and most were consistent with placebo effects; triamcinolone had the highest probability of exceeding the MID at weeks 2-6.
Pereira TV, Saadat P, Bobos P, et al. — Effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis based on large randomized trials: A systematic review and network meta-analysis. Osteoarthritis and Cartilage, 2025. DOI: 10.1016/j.joca.2024.08.014.
-
A meta-analysis of 73 articles covering 5,895 patients quantified the PLACEBO response to intra-articular injection in knee osteoarthritis: statistically and clinically significant improvements in pain, function and quality of life at 1, 3 and 6 months, with responder rates above 50% at each of those points, declining by 12 months. The placebo response was stronger in trials with more female participants and in more recently published trials. This is why an uncontrolled 'our patients improved' figure carries almost no information.
Previtali D, Boffa A, Di Laura Frattura G, et al. — Placebo response to intra-articular injections in knee osteoarthritis: magnitude, evolution over time, and influencing factors. A systematic review and meta-analysis with meta-regression. EFORT Open Reviews, 2025. DOI: 10.1530/EOR-2025-0022.
-
The devices used to spin PRP at the point of care are cleared by FDA as clinical centrifuges, product code JQC, a Class I device under 21 CFR 862.2050 - for example the Biomet GPS Platelet Separation Kit (K030555, cleared 2003) and the Harvest SmartPrep2 / SmartPrep Platelet Concentration System (K103340, cleared 2010). That clearance covers the equipment that separates blood. It is not an FDA approval of platelet-rich plasma as a treatment for osteoarthritis, tendinopathy or any other orthopedic condition, and copy must never blur the two.
U.S. Food and Drug Administration (Center for Devices and Radiological Health) — 510(k) Premarket Notification database and Product Classification: JQC, Centrifuges (Micro, Ultra, Refrigerated) For Clinical Use, 21 CFR 862.2050. FDA accessdata (CDRH device databases), 2003.
-
Medicare's national coverage policy covers autologous platelet-rich plasma ONLY for patients with chronic non-healing diabetic, pressure and/or venous wounds, and only within an approved coverage-with-evidence-development clinical study. There is no Medicare national coverage for PRP in osteoarthritis or tendinopathy, which is why these injections are billed to the patient as cash-pay.
Centers for Medicare & Medicaid Services — Autologous Platelet-rich Plasma (Coverage with Evidence Development). CMS.gov, 2024.
-
PATH-2 randomised 230 adults with acute Achilles tendon rupture managed non-surgically to PRP or a placebo dry-needle injection across 19 UK hospitals, with a central laboratory confirming the PRP was of good quality with the expected growth-factor content. At 24 weeks there was no detectable difference in muscle-tendon function (limb symmetry index 34.7% versus 38.5%; adjusted mean difference -3.9%; 95% CI -10.5% to 2.7%) or in any secondary outcome or adverse-event rate.
Keene DJ, Alsousou J, Harrison P, et al. — Platelet rich plasma injection for acute Achilles tendon rupture: PATH-2 randomised, placebo controlled, superiority trial. BMJ, 2019. DOI: 10.1136/bmj.l6132.
Want someone to examine the sore joint?
At QC Kinetix, a trained medical person will examine your joint and review your health. The office may discuss non-surgery regenerative choices, including PRP prepared there from your blood.
The Chandler office is at 1100 S. Dobson Road, Suite 210. Call (602) 837-PAIN to confirm the time, the examiner's job title and what to bring.
Talk to the clinic team